Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Innovent Biopharmaceutical Technology (hangzhou) Co., Ltd.

Clinical trials sponsored by Innovent Biopharmaceutical Technology (hangzhou) Co., Ltd., explained in plain language.

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 1

Triple-Drug attack on stomach cancer shows promise in major trial

Disease control Not yet recruiting

This study tests whether adding a second immunotherapy drug (ipilimumab) to the standard combination of sintilimab and chemotherapy helps shrink stomach tumors before surgery and keeps cancer from coming back afterward. About 720 adults with resectable stomach or gastroesophageal…

Phase: PHASE2, PHASE3 • Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC